{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:18:27Z","timestamp":1770909507220,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11695-022-06153-2","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T02:02:44Z","timestamp":1655172164000},"page":"2682-2695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Benefit of Bariatric Surgery on Histological Features of Metabolic Associated Fatty Liver Disease Assessed Through Noninvasive Methods"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7799-0503","authenticated-orcid":false,"given":"Diego","family":"Meneses","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Olveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Corripio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda dC","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00edriam","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Calvo-Vi\u00f1uelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noem\u00ed","family":"Gonz\u00e1lez-P\u00e9rez-de-Villar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana I.","family":"de-Cos-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"6153_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"6153_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328\u201357.","journal-title":"Hepatology"},{"key":"6153_CR3","doi-asserted-by":"crossref","unstructured":"Katsiki N, Perez-Martinez P, Anagnostis P, et al. Is nonalcoholic fatty liver disease indeed the hepatic manifestation of metabolic syndrome? Curr Vasc Pharmacol [Internet]. 2018;16:219\u201327. Available from: http:\/\/www.eurekaselect.com\/153468\/article","DOI":"10.2174\/1570161115666170621075619"},{"key":"6153_CR4","doi-asserted-by":"publisher","unstructured":"Sanyal AJ. Past, present and future perspectives in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol [Internet]. Springer US; 2019;16:377\u201386. Available from: https:\/\/doi.org\/10.1038\/s41575-019-0144-8","DOI":"10.1038\/s41575-019-0144-8"},{"key":"6153_CR5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jhep.2006.06.013","volume":"45","author":"M Machado","year":"2006","unstructured":"Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006;45:600\u20136.","journal-title":"J Hepatol"},{"key":"6153_CR6","doi-asserted-by":"publisher","unstructured":"Rinella ME, Tacke F, Sanyal AJ, et al. Report on the AASLD\/EASL joint workshop on clinical trial endpoints in NAFLD. J Hepatol [Internet]. the American Association for the Study of Liver Diseases, the European Association for the Study of the Liver; 2019;71:823\u201333. Available from: https:\/\/doi.org\/10.1016\/j.jhep.2019.04.019","DOI":"10.1016\/j.jhep.2019.04.019"},{"key":"6153_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149:367-378.e5.","journal-title":"Gastroenterology"},{"key":"6153_CR8","doi-asserted-by":"crossref","unstructured":"Zelber-Sagi S, Kessler A, Brazowsky E, et al. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol [Internet]. 2006;4:639\u201344. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16630771","DOI":"10.1016\/j.cgh.2006.02.004"},{"key":"6153_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","volume":"387","author":"MJ Armstrong","year":"2016","unstructured":"Armstrong MJ, Gaunt P, Aithal GP, et al. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet. 2016;387:679\u201390.","journal-title":"Lancet"},{"key":"6153_CR10","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","volume":"384","author":"PN Newsome","year":"2021","unstructured":"Newsome PN, Buchholtz K, Cusi K, et al. A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med. 2021;384:1113\u201324.","journal-title":"N Engl J Med"},{"key":"6153_CR11","doi-asserted-by":"crossref","unstructured":"Lassailly G, Caiazzo R, Buob D, et al. Bariatric surgery reduces features of non-alcoholic steatohepatitis in morbidly obese patients. Gastroenterology [Internet]. Elsevier, Inc; 2015;149:1\u201310. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508515005703","DOI":"10.1053\/j.gastro.2015.04.014"},{"key":"6153_CR12","doi-asserted-by":"crossref","unstructured":"Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA [Internet]. 2004;292:1724\u201337. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15479938","DOI":"10.1001\/jama.292.14.1724"},{"key":"6153_CR13","doi-asserted-by":"crossref","unstructured":"Ziogas IA, Zapsalis K, Giannis D, et al. Metabolic syndrome and liver disease in the era of bariatric surgery: what you need to know! World J Hepatol [Internet]. 2020;12:709\u201321. Available from: https:\/\/www.wjgnet.com\/1948-5182\/full\/v12\/i10\/709.htm","DOI":"10.4254\/wjh.v12.i10.709"},{"key":"6153_CR14","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.cgh.2018.10.017","volume":"17","author":"Y Lee","year":"2019","unstructured":"Lee Y, Doumouras AG, Yu J, et al. Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17:1040-1060.e11.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6153_CR15","doi-asserted-by":"crossref","unstructured":"Fakhry TK, Mhaskar R, Schwitalla T, et al. Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis. Surg Obes Relat Dis. Elsevier Inc.; 2019;15:502\u201311.","DOI":"10.1016\/j.soard.2018.12.002"},{"key":"6153_CR16","doi-asserted-by":"crossref","unstructured":"de Brito e Silva MB, Tustumi F, de Miranda Neto AA, et al. Gastric bypass compared with sleeve gastrectomy for nonalcoholic fatty liver disease: a systematic review and meta-analysis. Obes Surg. 2021;31:2762\u201372.","DOI":"10.1007\/s11695-021-05412-y"},{"key":"6153_CR17","doi-asserted-by":"publisher","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology [Internet]. Elsevier, Inc; 2019;156:1264\u20131281.e4. Available from: https:\/\/doi.org\/10.1053\/j.gastro.2018.12.036","DOI":"10.1053\/j.gastro.2018.12.036"},{"key":"6153_CR18","first-page":"477","volume":"101","author":"FC Kruger","year":"2011","unstructured":"Kruger FC, Daniels CR, Kidd M, et al. APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD\/NASH. South African Med J. 2011;101:477\u201380.","journal-title":"South African Med J"},{"key":"6153_CR19","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43:1317\u201325.","journal-title":"Hepatology"},{"key":"6153_CR20","first-page":"986","volume":"36","author":"X Forns","year":"2002","unstructured":"Forns X, Ampurdan\u00e8s S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002;36:986\u201392.","journal-title":"Hepatology"},{"key":"6153_CR21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846\u201354.","journal-title":"Hepatology"},{"key":"6153_CR22","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gut.2007.146019","volume":"57","author":"SA Harrison","year":"2008","unstructured":"Harrison SA, Oliver D, Arnold HL, et al. Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57:1441\u20137.","journal-title":"Gut"},{"key":"6153_CR23","doi-asserted-by":"publisher","unstructured":"Ampuero J, Pais R, Aller R, et al. Development and validation of Hepamet Fibrosis Scoring system\u2014a simple, noninvasive test to identify patients with nonalcoholic fatty liver disease with advanced fibrosis. Clin Gastroenterol Hepatol [Internet]. Elsevier, Inc; 2019; Available from: https:\/\/doi.org\/10.1016\/j.cgh.2019.05.051","DOI":"10.1016\/j.cgh.2019.05.051"},{"key":"6153_CR24","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","volume":"118","author":"V Ratziu","year":"2000","unstructured":"Ratziu V, Giral P, Charlotte F, et al. Liver fibrosis in overweight patients. Gastroenterology. 2000;118:1117\u201323.","journal-title":"Gastroenterology"},{"key":"6153_CR25","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s11695-014-1489-2","volume":"25","author":"E Cazzo","year":"2015","unstructured":"Cazzo E, Jimenez LS, Pareja JC, et al. Effect of Roux-en-y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study. Obes Surg. 2015;25:982\u20135.","journal-title":"Obes Surg"},{"key":"6153_CR26","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s11695-018-03676-5","volume":"29","author":"SC Yeo","year":"2019","unstructured":"Yeo SC, Ong WM, Cheng KSA, et al. Weight loss after bariatric surgery predicts an improvement in the non-alcoholic fatty liver disease (NAFLD) fibrosis score. Obes Surg. 2019;29:1295\u2013300.","journal-title":"Obes Surg"},{"key":"6153_CR27","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1007\/s11695-018-3286-9","volume":"28","author":"LS Jimenez","year":"2018","unstructured":"Jimenez LS, Mendon\u00e7a Chaim FH, Mendon\u00e7a Chaim FD, et al. Impact of weight regain on the evolution of non-alcoholic fatty liver disease after Roux-en-Y gastric bypass: a 3-year follow-up. Obes Surg. 2018;28:3131\u20135.","journal-title":"Obes Surg"},{"key":"6153_CR28","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1007\/s11695-017-3012-z","volume":"28","author":"F Nickel","year":"2018","unstructured":"Nickel F, Tapking C, Benner L, et al. Bariatric surgery as an efficient treatment for non-alcoholic fatty liver disease in a prospective study with 1-year follow-up: BariScan study. Obes Surg. 2018;28:1342\u201350.","journal-title":"Obes Surg"},{"key":"6153_CR29","doi-asserted-by":"crossref","unstructured":"Rubio MA, Salas-Salvad\u00f3 J, Barbany M, et al. Consenso Seedo 2007 Para La Evaluaci\u00f3n Del Sobrepeso Y La Obesidad Y El Establecimiento De Criterios De Intervenci\u00f3n Terap\u00e9utica. Rev Espa\u00f1ola Obes [Internet]. 2007;7\u201348. Available from: http:\/\/medcontent.metapress.com\/index\/A65RM03P4874243N.pdf","DOI":"10.1016\/S0025-7753(07)72531-9"},{"key":"6153_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"6153_CR31","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1053\/j.gastro.2006.02.024","volume":"130","author":"P Mathurin","year":"2006","unstructured":"Mathurin P, Gonzalez F, Kerdraon O, et al. The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology. 2006;130:1617\u201324.","journal-title":"Gastroenterology"},{"key":"6153_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1055\/s-0034-1371083","volume":"34","author":"DE Kleiner","year":"2014","unstructured":"Kleiner DE, Berk PD, Hsu JY, et al. Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the Longitudinal Assessment of Bariatric Surgery (LABS) study. Semin Liver Dis. 2014;34:98\u2013107.","journal-title":"Semin Liver Dis"},{"key":"6153_CR33","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology. 2009;49:1017\u201344.","journal-title":"Hepatology"},{"key":"6153_CR34","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"6153_CR35","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/hep.25889","volume":"56","author":"P Bedossa","year":"2012","unstructured":"Bedossa P, Poitou C, Veyrie N, et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology. 2012;56:1751\u20139.","journal-title":"Hepatology"},{"key":"6153_CR36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2337\/dc16-0236","volume":"39","author":"F Rubino","year":"2016","unstructured":"Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39:861\u201377.","journal-title":"Diabetes Care"},{"key":"6153_CR37","doi-asserted-by":"crossref","unstructured":"Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg [Internet]. 2007;17:565\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17658011","DOI":"10.1007\/s11695-007-9116-0"},{"key":"6153_CR38","doi-asserted-by":"publisher","unstructured":"Mummadi RR, Kasturi KS, Chennareddygari S, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol [Internet]. AGA Institute; 2008;6:1396\u2013402. Available from: https:\/\/doi.org\/10.1016\/j.cgh.2008.08.012","DOI":"10.1016\/j.cgh.2008.08.012"},{"key":"6153_CR39","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1007\/s11695-015-1691-x","volume":"25","author":"G Bower","year":"2015","unstructured":"Bower G, Toma T, Harling L, et al. Bariatric surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology. Obes Surg. 2015;25:2280\u20139.","journal-title":"Obes Surg"},{"key":"6153_CR40","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1007\/s11695-019-03705-x","volume":"29","author":"I Perysinakis","year":"2019","unstructured":"Perysinakis I, Pappis HC, Margaris E. Current controversies in metabolic surgery for nonalcoholic fatty liver disease. Obes Surg. 2019;29:1058\u201367.","journal-title":"Obes Surg"},{"key":"6153_CR41","doi-asserted-by":"publisher","unstructured":"Mathurin P, Hollebecque A, Arnalsteen L, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology [Internet]. AGA Institute American Gastroenterological Association; 2009;137:532\u201340. Available from: https:\/\/doi.org\/10.1053\/j.gastro.2009.04.052","DOI":"10.1053\/j.gastro.2009.04.052"},{"key":"6153_CR42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1467-789X.2010.00802.x","volume":"12","author":"H Ashrafian","year":"2011","unstructured":"Ashrafian H, Athanasiou T, Li JV, et al. Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass. Obes Rev. 2011;12:257\u201372.","journal-title":"Obes Rev"},{"key":"6153_CR43","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/MEG.0000000000000375","volume":"27","author":"G Bower","year":"2015","unstructured":"Bower G, Athanasiou T, Isla AM, et al. Bariatric surgery and nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2015;27:755\u201368.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6153_CR44","doi-asserted-by":"publisher","unstructured":"Keitel V, H\u00e4ussinger D. Perspective: TGR5 (Gpbar-1) in liver physiology and disease. Clin Res Hepatol Gastroenterol [Internet]. Elsevier Masson SAS; 2012;36:412\u20139. Available from: https:\/\/doi.org\/10.1016\/j.clinre.2012.03.008","DOI":"10.1016\/j.clinre.2012.03.008"},{"key":"6153_CR45","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/liv.12226","volume":"33","author":"S Verma","year":"2013","unstructured":"Verma S, Jensen D, Hart J, et al. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int. 2013;33:1398\u2013405.","journal-title":"Liver Int"},{"key":"6153_CR46","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","volume":"37","author":"P Mofrad","year":"2003","unstructured":"Mofrad P, Contos MJ, Haque M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003;37:1286\u201392.","journal-title":"Hepatology"},{"key":"6153_CR47","doi-asserted-by":"publisher","unstructured":"Baldwin D, Chennakesavalu M, Gangemi A. Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria. Surg Obes Relat Dis [Internet]. Elsevier Inc.; 2019;15:2123\u201330. Available from: https:\/\/doi.org\/10.1016\/j.soard.2019.09.060","DOI":"10.1016\/j.soard.2019.09.060"},{"key":"6153_CR48","doi-asserted-by":"crossref","unstructured":"Meneses D, Olveira A, Corripio R, et al. Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity. Endocrinol Diabetes y Nutr. 2021","DOI":"10.1016\/j.endinu.2021.04.007"},{"key":"6153_CR49","doi-asserted-by":"publisher","unstructured":"Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol [Internet]. Nature Publishing Group; 2017;112:18\u201335. Available from: https:\/\/doi.org\/10.1038\/ajg.2016.517","DOI":"10.1038\/ajg.2016.517"},{"key":"6153_CR50","doi-asserted-by":"publisher","unstructured":"Udelsman BV, Corey K, Hutter MM, et al. Use of noninvasive scores for advanced liver fibrosis can guide the need for hepatic biopsy during bariatric procedures. Surg Obes Relat Dis [Internet]. Elsevier Inc.; 2021;17:292\u20138. Available from: https:\/\/doi.org\/10.1016\/j.soard.2020.09.037","DOI":"10.1016\/j.soard.2020.09.037"},{"key":"6153_CR51","doi-asserted-by":"publisher","unstructured":"Lassailly G, Caiazzo R, Ntandja-Wandji LC, et al. Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis. Gastroenterology [Internet]. Elsevier, Inc; 2020;159:1290\u20131301.e5. Available from: https:\/\/doi.org\/10.1053\/j.gastro.2020.06.006","DOI":"10.1053\/j.gastro.2020.06.006"},{"key":"6153_CR52","doi-asserted-by":"crossref","unstructured":"Care D, Suppl SS. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142020. Diabetes Care. 2020;43:S14\u201331","DOI":"10.2337\/dc20-S002"},{"key":"6153_CR53","doi-asserted-by":"crossref","unstructured":"Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome. Circulation [Internet]. 2005;112:2735\u201352. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16157765","DOI":"10.1161\/CIRCULATIONAHA.105.169404"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-06153-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-022-06153-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-06153-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T14:32:32Z","timestamp":1657549952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-022-06153-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["6153"],"URL":"https:\/\/doi.org\/10.1007\/s11695-022-06153-2","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"assertion":[{"value":"17 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript has not been published previously (partly or in full) or submitted to more than one journal for simultaneous consideration. Informed consent was obtained from each patient included in the study. The study was approved by the Hospital Ethics Committee and registered (HULP: PI-2824); it conforms to the ethical guidelines of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}